Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project

Fig. 3

Boxplot comparing the new biomarkers before the switch and after one and two years of treatment. Graphical representation of the mean results for the new biomarkers before eliglustat treatment and after one and two years A Hepcidine concentration; B Lipocaline-2 concentration; C Catepsine-S concentration; D)YKL-40 concentration. *p value < 0.05; **p value < 0.01; ***p value < 0.001 and ****p value < 0.0001

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172